Logotype for LB Group Co Ltd

LB Group (002601) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for LB Group Co Ltd

Q2 2024 earnings summary

13 Jun, 2025

Executive summary

  • Revenue for H1 2024 reached ¥13.79 billion, up 4.10% year-over-year; net profit attributable to shareholders was ¥1.72 billion, up 36.40% year-over-year.

  • Gross margin improved to 33.51% for titanium dioxide, with overall profitability rising despite cost pressures.

  • Titanium dioxide and sponge titanium production and sales hit record highs, with international sales accounting for 58.61% of titanium dioxide sales.

  • The company maintained a strong cash position, with net cash from operating activities up 67.2% year-over-year.

  • The company completed a major succession in control, with Ms. Xu Ran becoming the new controlling shareholder and actual controller after the passing of Mr. Xu Gang.

Financial highlights

  • Operating income: ¥13.79 billion, up 4.10% year-over-year.

  • Net profit attributable to shareholders: ¥1.72 billion, up 36.40% year-over-year.

  • Basic and diluted EPS: ¥0.72, up 35.85% and 38.46% year-over-year, respectively.

  • Net cash from operating activities: ¥1.37 billion, up 67.2% year-over-year.

  • Total assets at period end: ¥67.70 billion, up 6.08% from year-end 2023.

  • Gross margin for titanium dioxide: 33.51%, up 7.67 percentage points year-over-year.

Outlook and guidance

  • The company expects continued growth in titanium dioxide and sponge titanium demand, driven by global economic recovery and infrastructure investment.

  • Plans to further expand production capacity and enhance R&D in new energy materials and titanium-related products.

  • Will continue to optimize product structure, reduce costs, and increase market share through innovation and internationalization.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more